Veracyte, Inc., a leading cancer diagnostics company, today announced that data from its market-leading Decipher Prostate Genomic Classifier are available in a new specialized database that the ...
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...
PRNewswire/ -- datma, a leader in federated real-world data access, and Rhythm Biosciences Ltd (ASX:RHY), a leading developer in predictive cancer diagnostics technology including its geneType ™ risk ...
Stockhead on MSN
Rhythm Biosciences teams up with US-based datma to accelerate genomic diagnostic innovation
Rhythm Biosciences (ASX:RHY) has inked an exploratory collaboration with US-based datma to evaluate how its datma.FED ...
Morning Overview on MSN
New tool exposes hidden cancer networks inside tumors
Cancer has long been treated as a mass of rogue cells, but the real power lies in the intricate communication networks ...
University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene ...
From the earliest days of the pandemic that shocked the world in 2020, researchers at Fred Hutch Cancer Center tracked the rapid evolution and spread of the virus that causes COVID-19 by studying how ...
New digital health system promises big gains in screening and treatment, but critics warn it increases the risks of data ...
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker innovation, announced today the presentation of seven studies at the upcoming ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc (VCYT). (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from its market-leading Decipher Prostate Genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback